NASDAQ
Oncotelic Therapeutics, Inc. (OTLC) has a revenue compound annual growth rate of -5.92% over 5 years and -3.01% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.